Articles Archives - Page 367 of 733

ThursdaySep 16, 2021 1:29 pm

MoneyShow Presents The World of ETF Investing Canada Virtual Expo Featuring 35+ World-Class Industry Experts

Date: Sept. 21-22, 2021 Virtual event Free registration Investors and traders are invited to attend the ETF Investing Canada Virtual Expo organized by MoneyShow on September 21-22, 2021. MoneyShow is trusted by millions of investors and traders for its global network of investing and trading experts The company is engaged in hosting award-winning in-person conferences, virtual events, and timely content online where industry experts offer their valuable insights on the current and future investment trends. With investors and traders increasingly using ETFs in their portfolios, this investment vehicle is attracting billions of dollars from the global financial ecosystem. However, with…

ThursdaySep 16, 2021 1:15 pm

Roth’s Investing in Women Cannabis Pioneers Investor Conference to Feature Female-Led Companies within the North American Cannabis Sector

Roth Capital Partners will host the “Women Cannabis Pioneers - The Brand Builders” event on September 28, 2021 The conference is set to feature approximately 25 privately held and female-led companies operating within the North American cannabis market Institutional investors will have an opportunity to discover new investment opportunities through their interaction with a host of emerging and lesser-known privately held companies Hosted by Roth Capital Partners (“Roth”), a widely respected independent securities research and trading firm specializing in emerging growth companies, the Investing in Women Cannabis Pioneers – The Brand Builders event has been uniquely designed to highlight the…

ThursdaySep 16, 2021 12:10 pm

Ideanomics Inc. (NASDAQ: IDEX) Growing its Strategic Advantage as a Global Provider of EV Mobility Solutions with the Appointment of New President of its Mobility Division

Robin Mackie new President of Ideanomics Mobility, as of September 8, 2021 Mackie will help the company to make the most out of its acquisitions, driving growth on its path to a zero-emission future He will also help Ideanomics expand its global talent pool to further develop its key advantage as a global provider of EV mobility solutions Mackie brings a wealth of knowledge and decades of experience in the EV sector On September 8, 2021, Ideanomics (NASDAQ: IDEX) announced the appointment of Robin Mackie as the new President of Ideanomics Mobility. Before he was appointed President, Mr. Mackie served…

ThursdaySep 16, 2021 11:51 am

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) to Launch as Seller on Amazon Marketplace; Commence NCIB of 5% Available Common Shares for Cancelation

The company will be utilizing Amazon’s fulfillment services, customer service, and network of affiliates in the U.S. and Canada The Amazon platform will also feature PlantX-label plant-based brands and products for sale The overall PlantX platform features a one-stop shop for all things plant-based, including grocery, meal delivery, The Plant Shop, weekly recipes, and more The company is preparing to begin NCIB on or around September 15, 2021, through September 14, 2022. The shares represent approximately 5% (6,071,757) of the common shares available for purchase. Through PI Financial Corp., the company will make the purchase of the common shares for…

ThursdaySep 16, 2021 11:40 am

Growth of China’s Tech Use Boosts Prospects for Mobile Services and Big Data Provider FingerMotion Inc. (FNGR)

U.S.-based FingerMotion is a mobile phone services and emerging big data technology company focused on the enormous prospects of China’s marketplace FingerMotion’s drive to develop its new Sapientus database IP has led to a significant agreement for providing big data to global insurance juggernaut Pacific Life’s Reinsurance division Pacific Life is among a number of outsider companies looking to enter China’s marketplace, and FingerMotion’s data is expected to help the company establish risk prediction profiles for its clientele China boasts a population of about 1.4 billion people, of whom more than half have adopted mobile phone technology during the past…

WednesdaySep 15, 2021 2:30 pm

Flora Growth Corp. (NASDAQ: FLGC) Receives its 2021 Commercial Export Quota Allocation from Colombian Government; Partners to Optimize Its Supply Chain By Implementing Global Cannabis Product Validation and Authentication Platform

Flora also recently announced it had received its 2021 commercial export quota allocation of 7,900 kilograms to cultivate, process, and distribute high-THC cannabis Flora Growth also announced it has entered into an agreement with Applied DNA Sciences, Inc. and TruTrace Technologies, Inc. FLGC will deploy the two companies’ integrated technology as part of its global cannabis product validation and authentication platform The integrated technology will tag, test, and track Flora’s cannabis and cannabis derivative products during transit across an international supply chain, providing enhanced transparency, traceability, and trust As an internationally focused company, Flora Growth (NASDAQ: FLGC) has always strived…

WednesdaySep 15, 2021 1:58 pm

AmpliTech Group Inc. (NASDAQ: AMPG) Expanding Through Focus on Quality, Performance, Hyper-Growth Opportunities

AmpliTech Group Inc. was recently featured in a Simply Wall Street article that observed multiple instances of insider buying Insider buying demonstrates that insiders believe in the company and anticipate the value of its shares will increase AmpliTech received two follow-on orders in June and July and reported a 117% quarter-over-quarter revenue increase in Q2 2021 The company is making strategic investments to position it for hyper-growth opportunities across several markets A recent Simply Wall Street article on AmpliTech Group (NASDAQ: AMPG) observed that in the last 12 months, multiple insiders acquired the company’s stock in large numbers – but…

WednesdaySep 15, 2021 1:37 pm

Potential for Psychedelic treatments Drives Mind Cure Health Inc.’s (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) Strategy for Therapeutics Profitability

Canada-based life sciences company Mind Cure Health is developing a synthetic form of the psychedelic drug ibogaine as part of its efforts to take a leading position in the burgeoning market for mental health therapies Psychedelics, strengthened by new clinical research driving scientific and legislative openness to the drugs’ possible benefits under controlled conditions, are overcoming stigmas that arose from recreational use of the drug Mind Cure Health is developing a proprietary software-as-a-service (SaaS) platform known as iSTRYM to optimize the healing journey between patients and caregivers The company recently released its year-end financial report and an analysis outlining…

WednesdaySep 15, 2021 1:16 pm

InnerScope Hearing Technologies Inc. (INND) Brings “Direct-to-Consumer Hearing Technology,” Poised to Disrupt Notoriously Underserved Hearing Aid Market

Hearing aids are prohibitively expensive for millions of Americans due to market concentration and the requirement that people must see a medical professional before purchasing hearing aids INND's marketing strategy brings the "Direct to Consumer" model to the hearing aid market amid growing recognition that the current traditional model may not be sustainable Matthew Moore, company's CEO, was featured on New to the Street, explaining how the company is committed to helping people get the hearing aids they need at significantly lower costs In a recent feature on New to the Street, Matthew Moore, InnerScope Hearing Technologies (OTC: INND)’s CEO,…

WednesdaySep 15, 2021 12:17 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Making Great Strides Toward Filing IND Application for Patented DehydraTECH(TM) Technology

Lexaria has begun the formal process of preparing an application for Investigational New Drug status for DehydraTECH(TM) and cannabidiol for hypertension The filing is being done with the assistance of an outside consultancy group, with Lexaria Bioscience designing non-clinical, clinical, and related product development required prior to the filing – all of which support Lexaria’s more ambitious goals There have been two successful human hypertension trials done with the combination DehydraTECH-CBD therapy in 2021, following an original human clinical study in 2018, and many animal studies Lexaria is making a strong case to support the efficacy of the technology for…

Site Search

Company Search

Category: Articles